Morgan Stanley Maintains Arxis at Overweight, Raises Target to $66
Morgan Stanley raised its price target from $62 to $66. The new target implies 20.2% upside from the Oct. 29 close of $54.93.
Morgan Stanley raised its price target from $62 to $66. The new target implies 20.2% upside from the Oct. 29 close of $54.93.